Literature DB >> 29722913

The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.

Minqing Jiang1,2, Rohit Rao1, Jincheng Wang1, Jiajia Wang1,3, Lingli Xu1, Lai Man Wu1, Jonah R Chan4, Huimin Wang2, Q Richard Lu1,3.   

Abstract

Proper peripheral myelination depends upon the balance between Schwann cell proliferation and differentiation programs. The serine/threonine kinase mTOR integrates various environmental cues to serve as a central regulator of cell growth, metabolism, and function. We report here that tuberous sclerosis complex 1 (TSC1), a negative regulator of mTOR activity, establishes a stage-dependent program for Schwann cell lineage progression and myelination by controlling cell proliferation and myelin homeostasis. Tsc1 ablation in Schwann cell progenitors in mice resulted in activation of mTOR signaling, and caused over-proliferation of Schwann cells and blocked their differentiation, leading to hypomyelination. Transcriptome profiling analysis revealed that mTOR activation in Tsc1 mutants resulted in upregulation of a polo-like kinase (PLK)-dependent pathway and cell cycle regulators. Attenuation of mTOR or pharmacological inhibition of polo-like kinases partially rescued hypomyelination caused by Tsc1 loss in the developing peripheral nerves. In contrast, deletion of Tsc1 in mature Schwann cells led to redundant and overgrown myelin sheaths in adult mice. Together, our findings indicate stage-specific functions for the TSC1-mTOR-PLK signaling axis in controlling the transition from proliferation to differentiation and myelin homeostasis during Schwann cell development.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Schwann cell; TSC; mTOR signaling; myelination; polo-like kinase; proliferation; tumor suppressor

Mesh:

Substances:

Year:  2018        PMID: 29722913      PMCID: PMC6185760          DOI: 10.1002/glia.23449

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  47 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.

Authors:  Diane L Sherman; Michiel Krols; Lai-Man N Wu; Matthew Grove; Klaus-Armin Nave; Yann-Gaël Gangloff; Peter J Brophy
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation.

Authors:  Suzana Atanasoski; Danielle Boller; Lukas De Ventura; Heidi Koegel; Matthias Boentert; Peter Young; Sabine Werner; Ueli Suter
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

Review 4.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

5.  mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells.

Authors:  Camilla Norrmén; Gianluca Figlia; Frédéric Lebrun-Julien; Jorge A Pereira; Martin Trötzmüller; Harald C Köfeler; Ville Rantanen; Carsten Wessig; Anne-Lieke F van Deijk; August B Smit; Mark H G Verheijen; Markus A Rüegg; Michael N Hall; Ueli Suter
Journal:  Cell Rep       Date:  2014-10-09       Impact factor: 9.423

6.  Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.

Authors:  Kathryn K Bercury; JinXiang Dai; Hilary H Sachs; Jared T Ahrendsen; Teresa L Wood; Wendy B Macklin
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

7.  Cell cycle control of Schwann cell proliferation: role of cyclin-dependent kinase-2.

Authors:  R Tikoo; G Zanazzi; D Shiffman; J Salzer; M V Chao
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

8.  The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.

Authors:  Péter Lénárt; Mark Petronczki; Martin Steegmaier; Barbara Di Fiore; Jesse J Lipp; Matthias Hoffmann; Wolfgang J Rettig; Norbert Kraut; Jan-Michael Peters
Journal:  Curr Biol       Date:  2007-02-08       Impact factor: 10.834

Review 9.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

10.  Zeb2 recruits HDAC-NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination.

Authors:  Lai Man Natalie Wu; Jincheng Wang; Andrea Conidi; Chuntao Zhao; Haibo Wang; Zachary Ford; Liguo Zhang; Christiane Zweier; Brian G Ayee; Patrice Maurel; An Zwijsen; Jonah R Chan; Michael P Jankowski; Danny Huylebroeck; Q Richard Lu
Journal:  Nat Neurosci       Date:  2016-06-13       Impact factor: 24.884

View more
  2 in total

1.  Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7.

Authors:  Breanne L Harty; Fernanda Coelho; Sarah E Pease-Raissi; Amit Mogha; Sarah D Ackerman; Amy L Herbert; Robert W Gereau; Judith P Golden; David A Lyons; Jonah R Chan; Kelly R Monk
Journal:  Nat Commun       Date:  2019-07-05       Impact factor: 14.919

2.  Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination.

Authors:  Gustavo Della-Flora Nunes; Emma R Wilson; Edward Hurley; Bin He; Bert W O'Malley; Yannick Poitelon; Lawrence Wrabetz; M Laura Feltri
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.